Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Jenner

Showing results (21-30 of 177) with videos related to

Pageof 18
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2013
A cup of coffee a day keeps dyskinesia away?Peter Jenner
Annals of Neurology|April 1, 2003
Oxidative stress in Parkinson's diseasePeter Jenner
Neurologic Clinics|August 13, 2013
Wearing off, dyskinesia, and the use of continuous drug delivery in Parkinson's diseasePeter Jenner
British Journal of Pharmacology|April 14, 2011
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the diseaseSusan Duty, Peter Jenner
Journal of Neural Transmission (Vienna, Austria : 1996)|September 2, 2025
COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusionPeter Jenner, Dag Nyholm
Parkinsonism & Related Disorders|December 17, 2016
Apomorphine - pharmacological properties and clinical trials in Parkinson's diseasePeter Jenner, Regina Katzenschlager
Biochemical Pharmacology|April 5, 2002
The distribution of copper, zinc- and manganese-superoxide dismutase, and glutathione peroxidase messenger ribonucleic acid in rat basal gangliaGrazyna Kunikowska, Peter Jenner
Nature Reviews. Neurology|October 4, 2018
Apomorphine infusion in advanced Parkinson diseaseAngelo Antonini, Peter Jenner
Brain Research|March 29, 2003
Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's diseaseGrazyna Kunikowska, Peter Jenner
Journal of Neural Transmission (Vienna, Austria : 1996)|March 12, 2020
Gerald Malcolm Stern b.1930 d.2018 : Neurologist and scientistPeter Jenner, Andrew Lees
Pageof 18

Showing results (21-30 of 177) with videos related to

Sort By:
Pageof 18
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2013
A cup of coffee a day keeps dyskinesia away?Peter Jenner
Annals of Neurology|April 1, 2003
Oxidative stress in Parkinson's diseasePeter Jenner
Neurologic Clinics|August 13, 2013
Wearing off, dyskinesia, and the use of continuous drug delivery in Parkinson's diseasePeter Jenner
British Journal of Pharmacology|April 14, 2011
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the diseaseSusan Duty, Peter Jenner
Journal of Neural Transmission (Vienna, Austria : 1996)|September 2, 2025
COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusionPeter Jenner, Dag Nyholm
Parkinsonism & Related Disorders|December 17, 2016
Apomorphine - pharmacological properties and clinical trials in Parkinson's diseasePeter Jenner, Regina Katzenschlager
Biochemical Pharmacology|April 5, 2002
The distribution of copper, zinc- and manganese-superoxide dismutase, and glutathione peroxidase messenger ribonucleic acid in rat basal gangliaGrazyna Kunikowska, Peter Jenner
Nature Reviews. Neurology|October 4, 2018
Apomorphine infusion in advanced Parkinson diseaseAngelo Antonini, Peter Jenner
Brain Research|March 29, 2003
Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's diseaseGrazyna Kunikowska, Peter Jenner
Journal of Neural Transmission (Vienna, Austria : 1996)|March 12, 2020
Gerald Malcolm Stern b.1930 d.2018 : Neurologist and scientistPeter Jenner, Andrew Lees
Pageof 18